|
MIR24, MIR29A, MIR151, MIR518F, MIR132-3P, MIR193B-3P, MIR320A, FBN1, COL3A1, INRS, ITGB1, MEF2A, TGBF2, MIR18B, MIR9, MIR32, MIR34C, MIR135A, hsa-MIR302C-3P, hsa-MIR-1243, hsa- MIR1274B, hsa-MIR-151A-3P, hsa-MIR-627-5P, hsa-MIR-155-5P, hsa-MIR518F-3P, h |
PCOS, menstrual disturbances with oligo- and anovulation, hyperandrogenism in terms of hirsutism, acne, alopecia,elevated T concentration, obesity, insulin resistance, low-grade inflammation, cardiovascular diseases. |
|
Rotterdam 2003 consensus criteria |
Related
|
49 PCOS women and 21 control women |
Our study provides evidence that the miRNA expression profile in follicular fluid is altered in PCOS and indicates that specific follicular fluid miRNAs are associated with phenotypical traits of PCOS. An altered miRNA profile holds potentials for new methods of PCOS patient stratification and may contribute to and in part explain the heterogeneous nature found within PCOS women. |